Pro 2013-021 (Jianfeng Group Corporate Bond Listing Announcement)-3
Release time:
2020-08-05
Section III Overview of Bond Issuance
1. Bond Name
Zhejiang Jianfeng Group Co., Ltd. 201 3 Corporate Bonds (Phase I) (hereinafter referred to as "13 Peak 01 " ).
2. Bond Issuance Approval Authority and Document No.
This issue of bonds has been approved by China Securities Regulatory Commission Securities Regulatory License [201 3 ] 595 .
Total 3. Bond Issue
The size of the bond issue is 3 .7 billion yuan.
4. The maturity of this bond variety
The maturity of this corporate bond is 5 years (with 3 end-of-year issuer interest rate increase option and investor resale option).
5. Bond Issuance Method and Issuance Object
(I) Issuance Method
This issue of bonds adopts a combination of online public offering for public investors and offline inquiry agreement placement for institutional investors. Online subscription is concluded in real time according to the principle of "time first" , and offline subscription is conducted in the form of the issuer and the sponsor (lead underwriter) sending a "Placing Payment Notice" to institutional investors or signing an "offline subscription agreement" with them.
(II) Issuing Object
() Online Issuing: Public Investors (except those prohibited by laws and regulations) who hold the securities accounts of A , B , D and F opened by the registration institution.
( 2 ) Offline: Institutional investors who open qualified securities accounts with a registrar (except where purchasers are prohibited by laws and regulations).
6. the lead underwriter and members of the underwriting syndicate
The bonds are underwritten by the sponsor (lead underwriter) Zheshang Securities Co., Ltd. by way of balance underwriting.
The sponsor and lead underwriter of the bonds are Zheshang Securities Co.
7. bond denominationcurrent bond denomination
100 yuan, issued at par value.
8. Bond Annual Interest Rate, Interest Rate and Debt Repayment MethodThe coupon rate of the current bond is
4.90 % , using single interest on an annual basis, excluding compound interest. Interest is paid once a year, the principal is repaid once due, and the last interest is paid with the payment of the principal. The interest payment and principal payment of the bonds shall be handled in accordance with the relevant business rules of the registered company.
The interest date of this bond is2013 6 April 5 , Interest Payment Date is 2006 to 2018 on June 6 5 of each year (in case of legal holidays or rest days postponed to the following 1 working days; No additional interest is charged for each interest payment). If the investor exercises the option of resale, the interest payment date for the resale of some bonds will be May 5 days of each year from 2014 to 2016 (in case of legal holidays or rest days, the interest payment will be postponed to 1 working days of the following ; No additional interest will be charged for each interest payment). The debt registration date for the interest payment of the bonds will be processed in accordance with the relevant regulations of the bond registration agency .
8. Credit Rating Agency and Bond Credit Rating
are comprehensively assessed by Joint Rating
. The credit rating of the current corporate bonds isAA + , and the main credit rating of the issuer is AA . 9. Guarantee
This
Company Bond is provided byTianjin Tianshili Group Co., Ltd. full unconditional and irrevocable joint and several liability guarantee . 10. Bond Trustee
Zheshang Securities Co., Ltd. .
11. Capital Verification of Raised Funds Confirmation
The total amount of bonds issued in this period is RMB 3
.2 billion yuan. The net raised funds after deducting the issuance expenses have been remitted to the bank account designated by the issuer on185 , June# , June 13 , 2013. Tianjian Certified Public Accountants (Special General Partnership) hired by the issuer has issued a capital verification report numbered Tianjian Inspection [2013]181 on the availability of the proceeds of the bonds. 12. Repurchase Transaction Arrangement
With the consent of the Shanghai Stock Exchange, a new pledge-type repurchase transaction can be carried out after the listing of the bonds. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of the registered company.Section IV Basic Information on Listing and Custody of Bonds
1. Basic Information on Listing of Current Corporate Bonds
With the consent of Shanghai Stock Exchange, this issue of bonds will be listed on Shanghai Stock Exchange from July 2
, 208 , 2013, 206
,. This issue of bonds is referred to as "13 Peak 01 " , and the securities code is "122227 " . The bonds have been applied to the Shanghai Stock Exchange, and new pledge repurchase transactions can be carried out after listing. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of China Securities Depository and Clearing Co., Ltd. 2. the basic situation of corporate bond custody According to the bond custody certificate provided by China Securities Depository and Clearing Co., Ltd. Shanghai Branch.
Section V Main Financial Status of the Issuer
Audit of the Financial Reports of the 1. Issuer in the Last Three Fiscal Years
The Financial Reports of the Company 2010
,2011 and
2012have been audited by Tianjian Certified Public Accountants (Special General Partnership), and issued respectively Tianjian Audit [2011]2058 , Tianjian Audit [2012]2018 and Tianjian Audit [2013]2818 standard unqualified audit reports. II. Financial and Accounting Data for the Last Three Years (I) Brief Consolidated Financial Statements
Brief Consolidated Balance Sheet
Unit: yuan
Project
| 2012 July | 31
2011 July | 31
2010 December July | 31
Total Current Assets |
| 598,184,425.67 |
679,445,334.64 |
583,348,017.58 |
Total Non-current Assets |
| 2,180,185,953.50 |
1,959,405,246.64 |
1,572,530,092.02 |
Assets |
| 2,778,370,379.17 |
2,638,850,581.28 |
2,155,878,109.60 |
current liabilities total |
| 1,013,708,681.11 |
893,010,462.35 |
,733, 298,189.60 |
total non-current liabilities |
| 118,223,645.25 |
189,908,882.59 |
164,905,055.88 |
liabilities total |
| 1,131,932,326.36 |
1,082,919,344.94 |
898,203,245.48 |
Total Shareholders' Equity Attributable to Parent Company |
| 1,514,999,218.55 |
1,420,100,618.20 |
1,157,941,656.48 |
|
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31